evidencegaps
Primary study · included by 1 review

Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells.

Xing 2022 · Xing Yixiao, Li Boya, He Jing, et al. · Frontiers in immunology · 2022

Included by

The Efficacy of Mesenchymal Stem Cell-Based Therapy for Sjögren's Syndrome: A Systematic Review and Meta-Analysis of Preclinical Studies.
Non-Cochrane · intervention · 2026 · cited as Xing 2022 · Table; Reference list; Supplementary Data 2

The review does not say which of its outcomes this study informs.

1 including review in total.